Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Multiple Sclerosis, Relapsing-Remitting"" wg kryterium: Temat


Tytuł:
Evaluating Relapse Knowledge in People with Multiple Sclerosis: A Cross-Sectional Study on the Development and Validation of the Relapse Knowledge Questionnaire.
Autorzy:
Wenzel L; Institute of Nursing Science, University of Cologne, Medical Faculty & University Hospital Cologne, Cologne, Germany; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: .
Haker M; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Heesen C; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kasper J; Institute of Nursing Sciences and Health Promotion, Faculty of Health Sciences, OsloMet, Metropolitan University, Oslo, Norway.
Köpke S; Institute of Nursing Science, University of Cologne, Medical Faculty & University Hospital Cologne, Cologne, Germany.
Rahn AC; Institute of Social Medicine and Epidemiology, Nursing Research Unit, University of Lübeck, Lübeck, Germany.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Mar; Vol. 83, pp. 105381. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/therapy
Humans ; Cross-Sectional Studies ; Surveys and Questionnaires ; Chronic Disease ; Recurrence ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Effect of high frequency repetitive transcranial magnetic stimulation (rTMS) on the balance and the white matter integrity in patients with relapsing-remitting multiple sclerosis: A long-term follow-up study.
Autorzy:
Yassine IA; Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Electronic address: dr_.
Shehata H; Faculty of Medicine, Cairo University, Cairo, Egypt.
Hamdy S; Faculty of Medicine, Cairo University, Cairo, Egypt.
Abdel-Naseer M; Faculty of Medicine, Cairo University, Cairo, Egypt.
Hassan T; Faculty of Medicine, Cairo University, Cairo, Egypt.
Sherbiny M; Police Hospitals, Cairo, Egypt.
Magdy E; Police Hospitals, Cairo, Egypt.
Elmazny A; Faculty of Medicine, Cairo University, Cairo, Egypt.
Shalaby N; Faculty of Medicine, Cairo University, Cairo, Egypt.
ElShebawy H; Faculty of Medicine, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Mar; Vol. 83, pp. 105471. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/therapy
Multiple Sclerosis*
White Matter*/diagnostic imaging
Humans ; Transcranial Magnetic Stimulation ; Follow-Up Studies ; Diffusion Tensor Imaging ; Prospective Studies ; Single-Blind Method ; Ataxia ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Screening for dysphagia in patients with relapsing-remitting multiple sclerosis.
Autorzy:
Kocica J; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Lasotova N; Department of Neurology, The University Hospital Brno, Czech Republic; Faculty of Education, Department of Special and Inclusive Education, Masaryk University, Brno, Czech Republic.
Kolcava J; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic. Electronic address: .
Svobodova M; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Hladikova M; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Stourac P; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Bednařík J; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Vlckova E; Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, The University Hospital Brno, Czech Republic.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Mar; Vol. 83, pp. 105418. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Deglutition Disorders*/diagnosis
Deglutition Disorders*/etiology
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Multiple Sclerosis*/complications
Humans ; Female ; Deglutition ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Autorzy:
Deri N; Centro de Investigaciones Diabaid, Autonomous City of Buenos Aires, Argentina.
Barboza A; Neurología Clínica, Mendoza, Argentina.
Vrech C; Centro Integral de Diagnóstico por Imágenes Marchegiani, Córdoba, Argentina.
Rey R; Neurology Department, Instituto Argentino de Investigación Neurológica (IADIN), Buenos Aires, Argentina.
Burgos M; Consultorios AMUGENAL, Salta, Argentina.
Fiol M; Department of Neurology, Institute for Neurological Research (FLENI) Buenos Aires, Argentina.
CalvoVildoso C; Centro de Neurología Rosario, Santa Fe, Argentina.
Patrucco L; Centro de Esclerosis Múltiple de Buenos Aires, Hospital Italiano de Buenos Aires, Argentina.
Jose G; Centro Médico Privado de Reumatología, Tucumán, Argentina (currently known as Centro de Investigaciones Médicas Tucumán), Argentina.
Aliberti P; Novartis Argentina S.A., Buenos Aires, Argentina.
Chirico D; Novartis Argentina S.A., Buenos Aires, Argentina.
Federico MB; Novartis Argentina S.A., Buenos Aires, Argentina.
Seifer G; Novartis Argentina S.A., Buenos Aires, Argentina.
Piedrabuena R; Instituto Modelo de Neurología Privado, Córdoba, Argentina. Electronic address: .
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Mar; Vol. 83, pp. 105421. Date of Electronic Publication: 2023 Dec 31.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/epidemiology
Multiple Sclerosis*/therapy
Multiple Sclerosis, Chronic Progressive*/diagnosis
Multiple Sclerosis, Chronic Progressive*/epidemiology
Multiple Sclerosis, Chronic Progressive*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/therapy
Adult ; Humans ; Cross-Sectional Studies ; Argentina/epidemiology ; Disease Progression
Czasopismo naukowe
Tytuł:
The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial.
Autorzy:
Abdelgaied MY; Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt.; Clinical Pharmacology and Pharmacogenomics Research Group, Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2E1, Canada.
Rashad MH; Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
El-Tayebi HM; Clinical Pharmacology and Pharmacogenomics Research Group, Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.
Solayman MH; Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt. .; Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. .
Pokaż więcej
Źródło:
Journal of neurology [J Neurol] 2024 Mar; Vol. 271 (3), pp. 1124-1132. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/pathology
Humans ; Adjuvants, Immunologic/therapeutic use ; Chronic Disease ; Interferon beta-1a/therapeutic use ; Prospective Studies ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł:
U-fiber diffusion kurtosis and susceptibility characteristics in relapsing-remitting multiple sclerosis may be related to cognitive deficits and neurodegeneration.
Autorzy:
Luo D; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Peng Y; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Zhu Q; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Zheng Q; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Luo Q; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Han Y; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Chen X; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China. xiaoya_.
Li Y; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1422-1433. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Multiple Sclerosis*/pathology
White Matter*/diagnostic imaging
White Matter*/pathology
Cognitive Dysfunction*/pathology
Humans ; Diffusion Tensor Imaging ; Brain/diagnostic imaging ; Brain/pathology ; Atrophy/pathology ; Cognition ; Diffusion Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
Autorzy:
Iaffaldano P; Department of Translational Biomedicine and Neurosciences-DiBraiN, University of Bari 'Aldo Moro', Piazza G. Cesare 11, 70124, Bari, Italy.
Lucisano G; Department of Translational Biomedicine and Neurosciences-DiBraiN, University of Bari 'Aldo Moro', Piazza G. Cesare 11, 70124, Bari, Italy.; Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
Guerra T; Department of Translational Biomedicine and Neurosciences-DiBraiN, University of Bari 'Aldo Moro', Piazza G. Cesare 11, 70124, Bari, Italy.
Patti F; Dipartimento di Scienze Mediche E Chirurgiche E Tecnologie Avanzate, GF Ingrassia, Università di Catania, Via Santa Sofia 78, 95123, Catania, Italy.; UOS Sclerosi Multipla, AOU Policlinico G Rodolico-San Marco, Università di Catania, Catania, Italy.
Cocco E; Department of Medical Science and Public Health, University of Cagliari/Centro Sclerosi Multipla, ATS Sardegna, Cagliari, Italy.
De Luca G; Centro Sclerosi MultiplaClinica Neurologica, Policlinico SS Annunziata, Università 'G. d'Annunzio', Chieti-Pescara, Italy.
Brescia Morra V; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Multiple Sclerosis Clinical Care and Research Center, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Pozzilli C; Department of Human Neurosciences, Sapienza University of Roma, Rome, Italy.
Zaffaroni M; Neuroimmunology Unit and Multiple Sclerosis Center, ASST Della Valle Olona, Hospital of Gallarate, Via Pastori 4, 21013, Gallarate, VA, Italy.
Ferraro D; Department of Neurosciences, Ospedale Civile di BaggiovaraAzienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Gasperini C; Dipartimento di Neuroscienze, Ospedale San Camillo-Forlanini, Rome, Italy.
Salemi G; Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy.
Bergamaschi R; IRCCS Mondino Foundation, Via Mondino 2, 27100, Pavia, Italy.
Lus G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Inglese M; Dipartimento di NeuroscienzeRiabilitazioneOftalmologiaGenetica e Scienze Materno-Infantili (DINOGMI), Universita' di Genova, Genova, Italy.; IRCCS, Ospedale Policlinico San Martino, Genova, Italy.
Romano S; Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sant'Andrea Hospital, Sapienza University of Rome, 00189, Rome, Italy.
Bellantonio P; Unit of Neurology, IRCCS Neuromed, Pozzilli, Italy.
Di Monte E; Center for Multiple Sclerosis, Hospital ASL 4 'Madonna delle Grazie', 75100, Matera, Italy.
Maniscalco GT; Neurology and Stroke Unit, MS Center 'A. Cardarelli Hospital', Naples, Italy.
Conte A; Department of Human Neurosciences, Sapienza, University of Rome, Rome, Italy.; Neurophysiopatology Unit, IRCCS Neuromed, Pozzilli, IS, Italy.
Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Vianello M; MS Unit, OU Neurology 'Ca' Foncello' Hospital, Treviso, Italy.
Torri Clerici VLA; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Di Sapio A; Department of Neurology, Regional Referral Multiple Sclerosis Center, University Hospital San Luigi Gonzaga, Orbassano, Turin, Italy.
Pesci I; Neurology Unit, Ospedale Vaio-Fidenza, Parma, Italy.
Granella F; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Totaro R; Centro Malattie Demielinizzanti-Clinica Neurologica, Ospedale San Salvatore, L'Aquila, Coppito, Italy.
Marfia GA; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
Danni MC; Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy.
Cavalla P; Centro Sclerosi Multipla e Neurologia 1 D.U, Dipartimento di Neuroscienze e Salute Mentale, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Valentino P; Istituto di neurologia, Università Magna Graecia Catanzaro, Catanzaro, Italy.
Aguglia U; Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Montepietra S; MS Centre, SMN Hospital, AUSL Reggio Emilia, Reggio Emilia, Italy.
Ferraro E; Centro SM, PO San Filippo Neri, ASL Roma 1, Rome, Italy.
Protti A; MS Center, Neuroscience Department, Niguarda Hospital, Milan, Italy.
Spitaleri D; MS Center, Neurology UNIT- Hospital San G. Moscati, Avellino, Italy.
Avolio C; MS Center, University of Neurology, Foggia, Italy.
De Riz M; Centro Sclerosi Multipla-Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Maimone D; Centro Sclerosi Multipla, ARNAS Garibaldi, Catania, Italy.
Cavaletti G; IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.
Gazzola P; SC Neurologia, Ospedale P. Antero Micone-ASL 3 Genovese, Genoa, Italy.
Tedeschi G; I Division of Neurology, Universita della Campania 'L. Vanvitelli', Naples, Italy.
Sessa M; Centro Provinciale Sclerosi Multipla, ASST papa Giovanni XXIII, Bergamo, Italy.
Rovaris M; MS Center, Scientific Institute Fondazione Don Carlo Gnocchi, Milan, Italy.
Di Palma F; SM Center Neurology Department, ASST Lariana S. Anna Hospital, Como, Italy.
Gatto M; Centro Malattie Demielinizzanti, Ospedale Generale Regionale F. Miulli, Acquaviva delle Fonti, Italy.
Cargnelutti D; SOC Neurologia-ASUFC, Udine, Italy.
De Robertis F; MS Ambulatory Neurological Clinical of Lecce, Lecce, Italy.
Logullo FO; UOC Neurologia, AST Pesaro, Urbino, Italy.
Rini A; Centro Sclerosi Multipla, Ospedale A. Perrino, Brindisi, Italy.
Meucci G; Ambulatorio Sclerosi MultiplaUnita' Operativa di Neurologia e Neurofisiopatologia, Spedali Riuniti di Livorno, Livorno, Italy.
Ardito B; Centro Sclerosi Mutipla UOC di Neurologia, Ospedale Della Murgia Fabio Perinei, Altamura, Italy.
Banfi P; Dipartimento di Neurologia, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Nasuelli D; ASST Della Valle Olona Presidio Ospedaliero di Saronno Ambulatorio Sclerosi Multipla, Saronno, Italy.
Paolicelli D; Department of Translational Biomedicine and Neurosciences-DiBraiN, University of Bari 'Aldo Moro', Piazza G. Cesare 11, 70124, Bari, Italy.
Rocca MA; Neurology Unit and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy.
Portaccio E; Department of NEUROFARBA, University of Florence, Viale Pieraccini 6, Florence, Italy.
Chisari CG; Dipartimento di Scienze Mediche E Chirurgiche E Tecnologie Avanzate, GF Ingrassia, Università di Catania, Via Santa Sofia 78, 95123, Catania, Italy.; UOS Sclerosi Multipla, AOU Policlinico G Rodolico-San Marco, Università di Catania, Catania, Italy.
Fenu G; Department of Medical Science and Public Health, University of Cagliari/Centro Sclerosi Multipla, ATS Sardegna, Cagliari, Italy.
Onofrj M; Centro Sclerosi MultiplaClinica Neurologica, Policlinico SS Annunziata, Università 'G. d'Annunzio', Chieti-Pescara, Italy.
Carotenuto A; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Multiple Sclerosis Clinical Care and Research Center, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
Ruggieri S; Department of Human Neurosciences, Sapienza University of Roma, Rome, Italy.
Tortorella C; Dipartimento di Neuroscienze, Ospedale San Camillo-Forlanini, Rome, Italy.
Ragonese P; Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy.
Nica M; Novartis Italia, Milan, Italy.
Amato MP; Department of NEUROFARBA, University of Florence, Viale Pieraccini 6, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Filippi M; Neurology and Neurorehabilitation Units, Neurophysiology Service, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy.
Trojano M; School of Medicine, University 'Aldo Moro' Bari, Piazza Giulio Cesare 11, Bari, Italy. .
Pokaż więcej
Corporate Authors:
Italian MS Register
Źródło:
Journal of neurology [J Neurol] 2024 Mar; Vol. 271 (3), pp. 1150-1159. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/chemically induced
Multiple Sclerosis, Chronic Progressive*/drug therapy
Humans ; Immunologic Factors/therapeutic use ; Cross-Sectional Studies ; Recurrence ; Italy/epidemiology
Czasopismo naukowe
Tytuł:
High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
Autorzy:
Hjæresen S; University of Southern Denmark, Department of Molecular Medicine, Campusvej 55, 5230 Odense M, Denmark.
Benedikz E; University of Southern Denmark, Faculty of Health Sciences, Campusvej 55, 5230 Odense M, Denmark.
Sejbaek T; University of Southern Denmark, Department of Regional Health Research, 5000 Odense, Denmark; University of Copenhagen, Department of Neurology, Southwest Jutland University Hospital, 6700 Esbjerg, Denmark.
Axelsson M; University of Gothenburg, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Novakova L; University of Gothenburg, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Zhang M; University of Southern Denmark, Department of Molecular Medicine, Campusvej 55, 5230 Odense M, Denmark; BRIDGE - Brain Research InterDisciplinary Guided Excellence, University of Southern Denmark, Odense, Denmark.
Lycke J; University of Gothenburg, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Illes Z; University of Southern Denmark, Department of Molecular Medicine, Campusvej 55, 5230 Odense M, Denmark; Odense University Hospital, Department of Neurology, Odense, Denmark; BRIDGE - Brain Research InterDisciplinary Guided Excellence, University of Southern Denmark, Odense, Denmark.
Fex-Svenningsen Å; University of Southern Denmark, Department of Molecular Medicine, Campusvej 55, 5230 Odense M, Denmark; BRIDGE - Brain Research InterDisciplinary Guided Excellence, University of Southern Denmark, Odense, Denmark. Electronic address: .
Pokaż więcej
Źródło:
Journal of the neurological sciences [J Neurol Sci] 2024 Feb 15; Vol. 457, pp. 122888. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Chronic Progressive*/diagnosis
Multiple Sclerosis, Chronic Progressive*/drug therapy
Multiple Sclerosis, Chronic Progressive*/cerebrospinal fluid
Multiple Sclerosis*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/cerebrospinal fluid
Macrophage Migration-Inhibitory Factors*
Humans ; Temperature
Czasopismo naukowe
Tytuł:
Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis.
Autorzy:
Raghib MF; Department of Neurology, Wayne State University School of Medicine, United States of America.
Bao F; Department of Neurology, Wayne State University School of Medicine, United States of America.
Elkhooly M; Department of Neurology, Wayne State University School of Medicine, United States of America; Department of Neurology, Southern Illinois University School of Medicine, Springfield, IL, United States of America; Department of Neurology and Psychiatry, Minia University, Minia, Egypt.
Bernitsas E; Department of Neurology, Wayne State University School of Medicine, United States of America; Detroit Medical Center, Detroit, MI, United States of America. Electronic address: .
Pokaż więcej
Źródło:
Journal of the neurological sciences [J Neurol Sci] 2024 Feb 15; Vol. 457, pp. 122884. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Multiple Sclerosis*/pathology
Humans ; Retinal Ganglion Cells/pathology ; Choroid Plexus/diagnostic imaging ; Retina/diagnostic imaging ; Retina/pathology ; Tomography, Optical Coherence/methods ; Atrophy/pathology
Czasopismo naukowe
Tytuł:
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis.
Autorzy:
Fujimori J; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: .
Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Pokaż więcej
Źródło:
Journal of neuroimmunology [J Neuroimmunol] 2024 Feb 15; Vol. 387, pp. 578280. Date of Electronic Publication: 2024 Jan 01.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/pathology
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Central Nervous System Diseases*
Neurodegenerative Diseases*/pathology
Humans ; Corpus Callosum/diagnostic imaging ; Corpus Callosum/pathology ; Retrospective Studies ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging ; Brain/pathology ; Atrophy/etiology ; Atrophy/pathology ; Thalamus/diagnostic imaging
Czasopismo naukowe
Tytuł:
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis.
Autorzy:
Marastoni D; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Foschi M; Neurology Unit, Department of Neuroscience, Multiple Sclerosis Center, S. Maria delle Croci Hospital, AUSL, Romagna, Ravenna, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Eccher C; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Crescenzo F; Neurology Unit, 'Mater Salutis' Hospital, Scaligera AULSS 9, Verona, Italy.
Mazziotti V; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Tamanti A; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Bajrami A; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Camera V; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Ziccardi S; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Guandalini M; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Bosello F; Eye Clinic, Department of Surgery, Dentistry, Maternity, and Infant, University of Verona, Verona, Italy.
Anni D; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Virla F; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Turano E; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Romoli M; Neurology and Stroke Unit, Ospedale 'Bufalini', Cesena, Italy.
Mariotti R; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Pizzini FB; Radiology and Neuroradiology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Bonetti B; Neurology A, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Calabrese M; Neurology B, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 09; Vol. 15, pp. 1343892. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Chitinases*
Humans ; Cladribine/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł:
Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey data.
Autorzy:
Le HH; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. .
Ken-Opurum J; Cerner Enviza, North Kansas City, MO, USA.
LaPrade A; Cerner Enviza, North Kansas City, MO, USA.
Maculaitis MC; Cerner Enviza, North Kansas City, MO, USA.
Sheehan JJ; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Feb 01; Vol. 24 (1), pp. 51. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Adult ; Humans ; Quality of Life ; Retrospective Studies ; Health Surveys ; Fatigue/epidemiology ; Fatigue/etiology
Czasopismo naukowe
Tytuł:
Author's addendum to the article: Fingolimod: Assay analysis of US generic capsule products reveals variation in fingolimod content beyond the recommended acceptance criteria.
Autorzy:
Greenwood W; Cycle Pharmaceuticals Ltd, Cambridge, UK.
Dickinson V; Cycle Pharmaceuticals Ltd, Cambridge, UK.
Fuller S; Cycle Pharmaceuticals Ltd, Cambridge, UK.
Wainwright C; Cycle Pharmaceuticals Ltd, Cambridge, UK. Electronic address: .
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Feb; Vol. 82, pp. 105393. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Letter
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/chemically induced
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/chemically induced
Humans ; Fingolimod Hydrochloride/therapeutic use ; Immunosuppressive Agents/therapeutic use
Opinia redakcyjna
Tytuł:
Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy.
Autorzy:
Akaishi T; Department of Neurology, Tohoku University, Sendai, Japan; Department of Education and Support for Regional Medicine, Tohoku University, Sendai, Japan.
Fujimori J; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: .
Nakashima I; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Feb; Vol. 82, pp. 105424. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/pathology
White Matter*/diagnostic imaging
White Matter*/pathology
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Humans ; Gray Matter/diagnostic imaging ; Gray Matter/pathology ; Choroid Plexus/diagnostic imaging ; Choroid Plexus/pathology ; Magnetic Resonance Imaging ; Brain/diagnostic imaging ; Brain/pathology ; Atrophy/pathology
Czasopismo naukowe
Tytuł:
Ocrelizumab in highly disabled progressive multiple sclerosis patients.
Autorzy:
Houtchens M; Neurology Department, Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA 02115, USA. Electronic address: .
Howard D; Neurology Department, Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA 02115, USA.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Feb; Vol. 82, pp. 105345. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/chemically induced
Disabled Persons*
Motor Disorders*
Multiple Sclerosis, Chronic Progressive*/complications
Multiple Sclerosis, Chronic Progressive*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/chemically induced
Antibodies, Monoclonal, Humanized*
Humans ; Middle Aged ; Aged ; Rituximab/therapeutic use ; Retrospective Studies ; Immunosuppressive Agents/therapeutic use ; Immunologic Factors/adverse effects
Czasopismo naukowe
Tytuł:
Serum sickness in a multiple sclerosis patient treated with ocrelizumab.
Autorzy:
Mantero V; MS Center, Department of Neurology, ASST Lecco, Via dell'Eremo 9/11, 23900, Lecco, Italy. .
Cordano C; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Balgera R; MS Center, Department of Neurology, ASST Lecco, Via dell'Eremo 9/11, 23900, Lecco, Italy.
Basilico P; MS Center, Department of Neurology, ASST Lecco, Via dell'Eremo 9/11, 23900, Lecco, Italy.
Novi G; Department of Neurosciences, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Salmaggi A; MS Center, Department of Neurology, ASST Lecco, Via dell'Eremo 9/11, 23900, Lecco, Italy.
Pokaż więcej
Źródło:
Journal of neurology [J Neurol] 2024 Feb; Vol. 271 (2), pp. 727-728. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Letter
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Serum Sickness*
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Chronic Progressive*
Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Immunologic Factors/adverse effects
Opinia redakcyjna
Tytuł:
Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
Autorzy:
Buch S; Department of Neurology, Wayne State University, Detroit, MI, USA.
Subramanian K; Department of Radiology, Wayne State University, Detroit, MI, USA.
Chen T; College of Engineering, University of Michigan, Ann Arbor, MI, USA.
Chen Y; Department of Neurology, Wayne State University, Detroit, MI, USA.
Larvie M; Department of Radiology, Wayne State University, Detroit, MI, USA.
Bernitsas E; Department of Neurology, Wayne State University, Detroit, MI, USA.
Haacke EM; Department of Neurology, Wayne State University, Detroit, MI, USA; Department of Radiology, Wayne State University, Detroit, MI, USA. Electronic address: .
Pokaż więcej
Źródło:
Magnetic resonance imaging [Magn Reson Imaging] 2024 Feb; Vol. 106, pp. 110-118. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/pathology
White Matter*/diagnostic imaging
White Matter*/pathology
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Humans ; Protons ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging ; Brain/pathology
Czasopismo naukowe
Tytuł:
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
Autorzy:
Jeantin L; Département de neurologie, unité de Médecine Intensive Réanimation à orientation neurologique, Sorbonne Université, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Shor N; Department of Neuroradiology, Sorbonne Université, AP-HP, Hôpital de la Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, Paris, France.
Pallix-Guyot M; Department of Neurology, Orléans Hospital, 14 avenue de l'Hôpital, Orléans, France.
Roos-Weil D; Department of Clinical Hematology, Pitié-Salpétrière University Hospital, 47-83 Bd de l'Hôpital, Paris, France.
Bellanger A; Département de Santé Publique, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, AP-HP, Hôpital Pitié Salpêtrière, Paris, France.
Le Garff-Tavernier M; Department of Biological Hematology, Sorbonne Université, AP-HP, Hôpital de la Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, 75013, Paris, France.
Papeix C; Department of Neurology, Hospital Foundation Adolphe de Rothschild, 25-29 rue Manin, Paris, France.
Weiss N; Département de neurologie, unité de Médecine Intensive Réanimation à orientation neurologique, Sorbonne Université, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.; Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France & Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC-RESPIRE) Sorbonne Université, Paris, France.
Pourcher V; Service des Maladies infectieuses et tropicales, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), AP-HP, Hôpital Pitié Salpêtrière, Paris, France. .
Pokaż więcej
Źródło:
Journal of neurology [J Neurol] 2024 Feb; Vol. 271 (2), pp. 729-732. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Leukoencephalopathy, Progressive Multifocal*/chemically induced
Leukoencephalopathy, Progressive Multifocal*/diagnostic imaging
Leukoencephalopathy, Progressive Multifocal*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
JC Virus*
Humans ; Fingolimod Hydrochloride/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Natalizumab/adverse effects
Raport
Tytuł:
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation.
Autorzy:
Sánchez-Sanz A; Neuroimmunology Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.
Muñoz-Viana R; Bioinformatics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.
Sabín-Muñoz J; Department of Neurology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
Moreno-Torres I; Demyelinating Diseases Unit, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.
Brea-Álvarez B; Radiodiagnostic Division, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
Rodríguez-De la Fuente O; Department of Neurology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
García-Merino A; Neuroimmunology Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.; Department of Neurology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.; Department of Medicine, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Red Española de Esclerosis Múltiple (REEM), 08028 Barcelona, Spain.
Sánchez-López AJ; Neuroimmunology Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.; Red Española de Esclerosis Múltiple (REEM), 08028 Barcelona, Spain.; Biobank, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 23; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/genetics
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/genetics
Lysophospholipids*
Sphingosine/*analogs & derivatives
Humans ; Fingolimod Hydrochloride/pharmacology ; Fingolimod Hydrochloride/therapeutic use ; Immunosuppressive Agents/adverse effects ; Leukocytes, Mononuclear ; NF-kappa B ; Gene Expression Profiling ; Biomarkers
Czasopismo naukowe
Tytuł:
Non-lesional white matter changes depicted by q-space diffusional MRI correlate with clinical disabilities in multiple sclerosis.
Autorzy:
Motegi H; Department of Neurology, Keio University School of Medicine, Tokyo, Japan; Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: .
Kufukihara K; Department of Neurology, Keio University School of Medicine, Tokyo, Japan; Department of Neurology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan. Electronic address: .
Kitagawa S; Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Sekiguchi K; Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Hata J; Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo, Japan; Department of Physiology, Keio University School of Medicine, Tokyo, Japan; Laboratory for Marmoset Neural Architecture, RIKEN Center for Brain Science, Wako, Japan. Electronic address: .
Fujiwara H; Center of Preventive Medicine, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Jinzaki M; Department of Radiology, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Okano H; Department of Physiology, Keio University School of Medicine, Tokyo, Japan; Laboratory for Marmoset Neural Architecture, RIKEN Center for Brain Science, Wako, Japan. Electronic address: .
Nakamura M; Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Iguchi Y; Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: .
Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Pokaż więcej
Źródło:
Journal of the neurological sciences [J Neurol Sci] 2024 Jan 15; Vol. 456, pp. 122851. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnostic imaging
Multiple Sclerosis*/pathology
White Matter*/diagnostic imaging
White Matter*/pathology
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Humans ; Diffusion Magnetic Resonance Imaging ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging ; Brain/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies